GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Inventories, Finished Goods

Cyfuse Biomedical KK (TSE:4892) Inventories, Finished Goods : 円37.18 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Inventories, Finished Goods?

Cyfuse Biomedical KK's quarterly finished goods declined from Mar. 2024 (円40.22 Mil) to Jun. 2024 (円37.37 Mil) and declined from Jun. 2024 (円37.37 Mil) to Dec. 2024 (円37.18 Mil).

Cyfuse Biomedical KK's annual finished goods increased from Dec. 2022 (円30.09 Mil) to Dec. 2023 (円34.86 Mil) and increased from Dec. 2023 (円34.86 Mil) to Dec. 2024 (円37.18 Mil).


Cyfuse Biomedical KK Inventories, Finished Goods Historical Data

The historical data trend for Cyfuse Biomedical KK's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Inventories, Finished Goods Chart

Cyfuse Biomedical KK Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
17.46 37.13 30.09 34.86 37.18

Cyfuse Biomedical KK Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.47 34.86 40.22 37.37 37.18

Cyfuse Biomedical KK Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Cyfuse Biomedical KK Business Description

Traded in Other Exchanges
N/A
Address
3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK Headlines

No Headlines